Your session is about to expire
← Back to Search
Imaging
Electromagnetic Acoustic Imaging for Liver Cancer
N/A
Waitlist Available
Led By Chirag Patel, MD
Research Sponsored by Enhanced Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
Study Summary
A single-centre, industry sponsored, proof-of-concept pilot study to assess the feasibility of Electromagnetic Acoustic Imaging (EMA) as an imaging platform in the visualization of hepatic tumours.
Eligible Conditions
- Liver Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
EMA (colour scale) images will be compared to baseline US grey-scale images for a specific target lesion, as determined by standard of care imaging (US, CT, MRI or PET) and/or histologically proven lesion in a given subject.
Secondary outcome measures
US grey-scale and EMA colour maps will be obtained from both target liver lesions and background liver tissue from the same subject and compared.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Electromagnetic Acoustic ImagingExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Enhanced MedicalLead Sponsor
Sunnybrook Health Sciences CentreOTHER
656 Previous Clinical Trials
1,551,407 Total Patients Enrolled
1 Trials studying Liver Cancer
8,000 Patients Enrolled for Liver Cancer
Chirag Patel, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger